DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Chlorpromazine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Genus, Pharm Assoc, Wockhardt, Abraxis Pharm, Dr Reddys, Eugia Pharma, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Cycle Pharms Ltd, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Lederle, Mayne Pharma, Purepac Pharm, Pvt Form, Sandoz, Sun Pharm, Upsher Smith Labs, Vangard, West Ward, Zydus, and Hikma Pharms. and is included in sixty-two NDAs.
The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
A generic version of CHLORPROMAZINE HYDROCHLORIDE was approved as chlorpromazine hydrochloride by ZYDUS on January 17th, 2020.
Recent Clinical Trials for CHLORPROMAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Noha Mahmoud Nasreldin Hassan||Phase 2/Phase 3|
|Cairo University||Phase 2/Phase 3|
|Centre Hospitalier St Anne||Phase 3|
Pharmacology for CHLORPROMAZINE HYDROCHLORIDE
|Drug Class||Phenothiazine |